ASAPbio newsletter vol 21: COVID-19 webinar, new board members, open access RFI

Illustration of coronavirus particle — This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).

Webinar: Rapid communication of COVID-19 research

Tuesday, March 31, 12pm-1:30pm ET (9am PT, 5pm BST, 6pm CEST – see in your time zone)

Join ASAPbio and the Knowledge Futures Group for a conversation about new ways of sharing scientific information relevant to the coronavirus pandemic via preprints, rapid peer review, and more. Individual talks will be followed by a round-table discussion and an audience Q&A period. Register here. (2020-04-06 update: watch recording here)

Introduction by Richard Wilder, Coalition for Epidemic Preparedness Innovations

Panelists

Dave O’Connor, University of Wisconsin
Richard Sever, bioRxiv and medRxiv, Cold Spring Harbor Laboratory
Michael Johansson, Outbreak Science
Daniela Saderi, PREreview

Welcoming new board members

We are happy to welcome five new members to our Board of Directors: Needhi Bhalla, Jesse Bloom, Iain Cheeseman, R. Dyche Mullins, and Mark Patterson. See the complete list on our about page.

Weigh in on open access: OSTP RFI deadline extended

The United States Office of Science and Technology Policy (OSTP) has released a Request for Information (RFI) on “Public Access to Peer-Reviewed Scholarly Publications, Data and Code Resulting From Federally Funded Research.” After an extension, the deadline to comment is April 6, 2020.

Read the notice and response instructions.

Want to recieve these messages in your inbox? Subscribe here.